English

Pharmaceutical companies

Health news

Why weight loss drugs aren't Denmark's trump card in Greenland dispute

ADVERTISEMENT

ADVERTISEMENT

More about this topic

Business

Pharma market shake-up: Bayer jumps, Novo Nordisk sinks 10%

Shares of Danish pharmaceutical giant Novo Nordisk fell sharply after its Alzheimer's drug failed to slow progression of the disease in a trial. Meanwhile, Germany's Bayer said their stroke-prevention drug showed positive results, pushing the share price through the roof.

Markets

AstraZeneca to list shares in New York, without leaving the UK

Amid concerns it might leave the UK, the pharma giant reaffirmed its commitment to the country, keeping its headquarters, primary listing, and tax base there.

Economy

The Ozempic ripple: When a single jab moves an entire market

As GLP-1 use spreads, grocers and restaurants see lighter baskets, airlines predict fuel savings and health systems eye lower costs—while Denmark sees a clipped GDP.

Health news

Young children are given ADHD drugs too quickly, study finds

US paediatricians often prescribe medication immediately after diagnosing 4- and 5-year-olds with ADHD, according to the analysis.

ADVERTISEMENT

Health news

EU approves new twice-yearly jab to prevent HIV

The new treatment option comes amid a rise in HIV cases in parts of Europe.

Health news

Eli Lilly’s daily weight loss pill succeeds in latest trial

Lilly said it plans to ask regulators to approve the drug by the end of 2025.

Healthcare

Eli Lilly hikes UK price of blockbuster weight loss drug Mounjaro

The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS).

Health news

Experimental pill helped with weight loss in Eli Lilly trial

Study participants lost an average of 12.4 per cent of their body weight over 72 weeks.

Markets

Pfizer earnings strong despite Trump’s new 'up to 250%' tariff threat

Pfizer beat earnings expectations and improved its outlook for the rest of the year, despite fresh statements from Trump announcing pharma tariffs next week.

Health news

EU-US trade deal leaves future of pharma tariffs uncertain

Despite a new EU-US trade deal, tariffs on pharmaceuticals remain uncertain and unchanged for now, pending the outcome of a US national security investigation that could later impose duties of up to 15%.

Business

AstraZeneca pledges $50bn investment in the US amid 200% tariff fears

British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in a bid to boost sales in its largest market.

Economy

President Trump: Pharma tariff is coming, Indonesia deal sealed

The US President announced a list of updates concerning US trade tariffs on Tuesday, including a deal with Indonesia and his plans to gradually increase tariffs on pharmaceutical imports.

Markets

EU pharma chief calls for European Nasdaq to boost biotech innovation

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, modelled after the US Nasdaq, to help retain biotech innovation and investment within the region.

Business Line

Uzbekistan expands pharma production with €1.2bn investment

In partnership with Center for the Production of Content for Mass Media under the Administration of the President of the Republic of Uzbekistan

Uzbekistan is rapidly scaling up its pharmaceutical sector with the launch of Tashkent Pharma Park — a €1.2 billion project uniting research, logistics, manufacturing and training.

Health news

Meet the company leveraging AI-backed physics tools for drug discovery

The start-up aims to use AI to drastically reduce the time and money it takes to develop new drugs.

Health news

Novo Nordisk CEO steps down amid competition for weight loss drugs

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991.